Non‐alcoholic fatty liver disease (NAFLD), or recently termed as metabolic dysfunction‐associated fatty liver disease (MAFLD), is a progressive metabolic condition characterised by hepatic lipid accumulation, inflammation, fibrosis and insulin resistance. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.